News & Blog

May 27, 2022 | Press Release
Multi-omics Startup Pleno Inc. Announces $15 Million in Pre-Series A Funding
May 18, 2022 | Press Release
ProJenX Names Life Sciences Industry Veteran Stan E. Abel as CEO
May 10, 2022 | Press Release
Aspen Neuroscience Announces $147.5 Million Series B Financing, Led by GV, LYFE Capital and Revelation Partners
May 04, 2022 | Blog Post
How Lessons Learned During COVID Will Shape the Future of Early Cancer Detection
April 12, 2022 | Press Release
Aspen Neuroscience Launches First Patient Screening Study for Planned Clinical Trial of Personalized Cell Replacement in Parkinson’s Disease
March 01, 2022 | In The News
ALS News Today: ProJenX Launches, Will Develop ALS Therapy Prosetin
March 01, 2022 | Press Release
ProJenX Announces First Person Dosed in Phase 1 Study of Prosetin
February 16, 2022 | Press Release
ProJenX launches to advance novel, targeted therapies for ALS and other brain diseases
January 12, 2022 | In The News
MEC SAB in the News: Fastest DNA sequencing technique helps undiagnosed patients find answers in mere hours
December 22, 2021 | Blog Post
Neuroscience Medicine: A New Frontier